-transparent.png){kind=logo}
1. beta-D-Galactopyranosylmethyl-p-nitrophenyltriazene can specificag detectable changes in cell viability or the activities of other hydrolases. 2. beta-D-Glucopyranosylmethyl-p-nitrophenyltriazene behaves similarly towards lysosomal beta-glucosidase, but also inactivates some alpha-glucosidase. 3. Both beta-galactosidase and beta-glucosidase activities in triazene-treated confluent fibroblast cultures recover exponentially; if zero-order enzyme production is assumed, turnover times of 10 and 5 days respectively can be estimated.
Related Publications
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
November 1977,
The Journal of clinical investigation,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
December 1973,
Biochemical pharmacology,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
February 1957,
The Biochemical journal,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
July 1986,
Biokhimiia (Moscow, Russia),
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
January 1982,
Advances in experimental medicine and biology,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
September 1973,
Biochimica et biophysica acta,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
December 1967,
The Journal of biological chemistry,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
July 1975,
The British journal of dermatology,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
November 1976,
Nature,
O P Van Diggelen, and
H Galjaard, and
M L Sinnott, and
P J Smith
April 1986,
Neurochemical research,
